The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy

20Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The genetic evaluation of dilated cardiomyopathy (DCM) has been challenging, owing in large part to marked genetic heterogeneity. However, lower costs from next-generation sequencing have enabled gene discovery and the expansion of genetic testing panels. These advances have improved molecular diagnostics and predictive testing in DCM. We provide a rationale and recommendation for clinical genetic testing in all DCM cases.

Cite

CITATION STYLE

APA

Morales, A., & Hershberger, R. E. (2015). The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy. Canadian Journal of Cardiology, 31(11), 1309–1312. https://doi.org/10.1016/j.cjca.2015.06.034

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free